 | eFFECTOR Therapeutics, Inc. | |||
| NCM : EFTR || Location: United States | ||||
$1.73-0.05 (-2.9%) |
0.19 M | 1.6 - 1.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.345 M |
| March 15, 2024 | 0.318 M |
| Feb. 29, 2024 | 0.222 M |
| Feb. 15, 2024 | 0.104 M |
| Jan. 31, 2024 | 0.109 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.68 | -3.42 | -103.21% |
| 09/30/2023 | -3.14 | -3.25 | -3.34% |
| 06/30/2023 | -5.04 | -4.25 | 15.72% |
| 03/31/2023 | -0.14 | -0.24 | -73.04% |
| 12/31/2022 | -6.07 | -5.50 | 9.38% |
EFTR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 3.687M | Shares Float | 3.375M |
| Short Float | 0.345M | Market Cap | 6.56M |
| Institution ownership | 17.57% | Insider ownership | 3.627% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -16.37 | Forward EPS | -2.03 |